Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Picard Medical, Inc. ( (PMI) ).
On November 26, 2025, Picard Medical, Inc. announced that Duffy Elmer will present in vitro data on the Emperor Total Artificial Heart at the 31st Annual Meeting of the International Society for Mechanical Circulatory Support in Vienna. The presentation will focus on the Emperor’s benchtop performance, highlighting its internal motor-driven design that enhances patient mobility and quality of life by eliminating the need for an external pneumatic driver.
More about Picard Medical, Inc.
Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, based in Tucson, Arizona. It is a leader in total artificial heart technology, offering the only commercially available artificial heart approved by the U.S. FDA and Health Canada. The SynCardia Total Artificial Heart is used for patients with end-stage heart failure and has been implanted in over 2,100 cases across 27 countries.
Average Trading Volume: 2,328,670
For an in-depth examination of PMI stock, go to TipRanks’ Overview page.